Pharma Capital

Featured articles

VIEW ALL ARTICLES

Featured companies

VentriPoint is a public company (TSXV: VPT) dedicated to making heart analysis convenient and ...
MaxCyte is a leader in cell transfection, bringing to market its patented flow electroporation...
Advanced Oncotherapy plc is a UK-based company focused on delivering a cost-effective proton-b...
WideCells Group PLC is a worldwide healthcare services company focused on collecting and stori...
Cynata Therapeutics (ASX:CYP) is listed on the Australian Securities Exchange.

Executive video interviews

VIEW ALL VIDEOS

Big picture investment ideas in Biotech Capital

VIEW ALL

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.